Helena Cirenajwis

发表

The clinical significance of BRAF and NRAS mutations in a clinic‐based metastatic melanoma cohort

K. Nielsen, H. Olsson, K. Harbst, 2013, The British journal of dermatology.

Molecular Subtypes of Melanoma. Biological and Clinical Significance.

H. Cirenajwis, Helena Cirenajwis, 2016 .

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer

Johan Staaf, Helena Cirenajwis, Martin Lauss, 2019, Briefings Bioinform..

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.

M. Ringnér, P. Lønning, Å. Borg, 2015, The Journal of investigative dermatology.

The Antiproliferative Effect of Dietary Fiber Phenolic Compounds Ferulic Acid and p-Coumaric Acid on the Cell Cycle of Caco-2 Cells

S. Oredsson, C. Hegardt, Morten Krogh, 2011, Nutrition and cancer.

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics

L. Saal, N. Hayward, H. Olsson, 2017, Molecular oncology.

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.

Frida Rosengren, Helena Cirenajwis, Martin Lauss, 2016, Cancer research.

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

Johan Staaf, Frida Rosengren, Markus Ringnér, 2015, Oncotarget.

Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047

Helena Cirenajwis, S. Oredsson, L. Marton, 2010, Anti-cancer drugs.

Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer

Å. Borg, K. Jirström, G. Jönsson, 2015, Oncotarget.

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer

J. Staaf, H. Brunnström, H. Cirenajwis, 2019, Scientific Reports.

Molecular and genetic diversity in the metastatic process of melanoma

L. Saal, H. Olsson, M. Lauss, 2014, The Journal of pathology.

Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours

L. Saal, M. Lauss, G. Jönsson, 2015, PeerJ.

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.

Å. Borg, H. Olsson, M. Lauss, 2016, Cancer research.

Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence

L. Saal, J. Staaf, P. Bendahl, 2019, Acta oncologica.